AcquisitionOther
CareDx, Inc. acquired target
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
CareDx, Inc. -> target · $447 Million
"And we took important strategic steps advancing our lead pipeline asset, AlloHeme, and agreeing to divest the Lab Products business to simplify our operating model and create focus, with the goal of expanding our AEBITDA margins." First Quarter 2026 Financial
Open source record (SEC) ↗